<DOC>
	<DOCNO>NCT01001767</DOCNO>
	<brief_summary>Several study show increased risk heart disease people HIV . In study investigator look effect Lovaza ( Omega-3 fatty acid ) improve endothelial function decrease inflammation may contribute increase risk . The investigator also study analyze coagulation inflammation marker .</brief_summary>
	<brief_title>Pilot Placebo Controlled Study With Lovaza Cardiovascular Disease</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>HIV+ Ages 1870 HIV1 RNA &lt; 400 copies/ml . On stable ART ( antiretroviral therapy ) regimen 12 week intent modify regimen , cumulative ART study entry 12 mo . Active infection Inflammation malignancy Uncontrolled diabetes hypothyroidism LDL ( low density lipoprotein ) cholesterol &gt; 160 triglyceride level &gt; 750 Framingham risk score &lt; 6 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Omega-3 Fatty Acids</keyword>
	<keyword>HIV</keyword>
	<keyword>Heart Disease</keyword>
	<keyword>Treatment experience</keyword>
</DOC>